Skip to main content
SMS Pharmaceuticals Ltd logo

SMS Pharmaceuticals Ltd — Investor Relations & Filings

Ticker · SMSPHARMA ISIN · INE812G01025 LEI · 335800XXEADQCB7GJ514 BSE.NS Manufacturing
Open in API
Filings indexed 747 across all filing types
Latest filing 2023-08-05 Call Transcript
Country IN India
Listing BSE.NS SMSPHARMA

About SMS Pharmaceuticals Ltd

https://smspharma.com/

SMS Pharmaceuticals Ltd specializes in the development and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. The organization operates multiple manufacturing units and research centers, maintaining compliance with international regulatory standards including USFDA approvals. Its core product portfolio covers therapeutic areas such as anti-ulcerants, anti-migraine agents, anti-hypertensives, and anti-retrovirals. Beyond its proprietary product line, the company provides Contract Research and Manufacturing Services (CRAMS), offering expertise in process development, chemical synthesis, and analytical validation. The company focuses on delivering high-quality chemical solutions through integrated research and development capabilities, supporting global supply chains with a commitment to technical excellence and operational efficiency.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 70% confidence The document is an invitation and intimation for an upcoming investor conference call scheduled to discuss the company's financial performance for the quarter ended June 30, 2023. It is addressed to stock exchanges and includes call details and participants. There is no actual financial data or report content included, only an announcement of the call event. Therefore, this document is best classified as a Call Transcript (CT) related announcement, but since it is only the invitation and not the transcript itself, it fits the category of Call Transcript (CT) as per the definitions provided, which includes full text transcripts of company conference calls. However, since this is only an invitation and not the transcript, the closest fitting category is Regulatory Filings (RNS) as a fallback for announcements that do not fit other categories. But given the specific mention of "Investor’s Conference Call" and the detailed call information, the best classification is Call Transcript (CT) with moderate confidence because it is related to the call but not the transcript itself.
2023-08-05 English
Board Meeting — SMS PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 08-Aug-2023 to consider and approve the Quarterly Unaudited Financial results of the Company fo…
Regulatory Filings
2023-08-01 English
Board Meeting — Financial Results/Other business matters
Board/Management Information Classification · 95% confidence The document is a notice from SMS Pharmaceuticals Limited addressed to stock exchanges about an upcoming Board Meeting scheduled for August 8, 2023. The purpose of the meeting is to consider and approve the unaudited financial results for the first quarter ended June 30, 2023. It also mentions the closure of the trading window in compliance with insider trading regulations. The document is a notification of a board meeting and related compliance information, not the financial results themselves or a detailed report. The document length is short (1751 characters) and it does not contain any financial data or analysis. Therefore, it is best classified as a Board/Management Information (MANG) filing, which covers announcements of board meetings and related management information.
2023-08-01 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding the submission of newspaper publications about the transfer of shares to the Investor Education Protection Fund (IEPF) related to unpaid/unclaimed dividends for the financial year 2015-2016. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulations 30 and 47. The content is about informing shareholders and the stock exchanges about the transfer of shares due to unpaid dividends, supported by newspaper advertisements. There is no financial data, earnings information, management discussion, or report attached or referenced as being attached. The document is an official regulatory announcement or intimation to stock exchanges about a compliance matter, not a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2023-07-19 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 30th June 2023. It is a compliance certificate from the Registrar and Share Transfer Agent confirming actions related to dematerialization of securities for the specified quarter. The document is addressed to stock exchanges and is a regulatory compliance filing rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data, nor is it an announcement of a report publication. It is primarily a regulatory compliance certificate. Therefore, it fits best under Regulatory Filings (RNS). The document length is short (2645 characters), consistent with a certificate or attestation rather than a full report.
2023-07-11 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a communication addressed to stock exchanges (BSE and NSE) regarding a newspaper advertisement about the dispatch of a Notice of Postal Ballot and information on remote e-voting. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 47 and 30. The content is about the announcement of the dispatch and publication of the postal ballot notice, not the postal ballot notice itself or the results of voting. The document length is about 13,849 characters, but the content is primarily an announcement of the notice dispatch and related advertisement publication, not a detailed report or voting results. Therefore, this fits best as a Regulatory Filing (RNS) because it is a regulatory announcement related to compliance and disclosure, but not a full report or voting result declaration.
2023-07-11 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.